Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The interaction between platelets and factor VII/VIIa.

Herbert K F Lau1

  • 1Department of Laboratory Medicine and Pathobiology, Room 2-015, St. Michael's Hospital, University of Toronto, 30 Bond Street, Toronto, Ont., Canada M5B 1W8. lauh@smh.toronto.on.ca

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
|May 3, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytotoxicity of nitric oxide donors in smooth muscle cells is dependent on phenotype, and mainly due to apoptosis.

Atherosclerosis·2003
Same author

Regulation of plasminogen activator inhibitor-1 secretion by urokinase and tissue plasminogen activator in rat epithelioid-type smooth muscle cells.

British journal of haematology·2002
Same journal

What's happening? Editorial comment: Insights on artificial intelligence, cell therapy and stem cell transplantation safety.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same journal

Red blood cell transfusion in elderly patients: Hemoglobin thresholds and clinical outcomes.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same journal

A personalized view on how artificial intelligence will change the future of multidirectional cell therapy: From design and engineering foundation to some healthcare applications.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same journal

The South African National Blood Service (SANBS): A new member of the world apheresis association.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same journal

Lipoprotein apheresis: From familial hypercholesterolemia and elevated lipoprotein(a) to emerging roles in peripheral arterial and renal disease.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same journal

Managing leukocytosis in malignant pertussis with white blood cell depletion: An effective alternative way to exchange transfusion.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
See all related articles

This review examines the role of platelets in blood coagulation, specifically how they might bind factor VIIa independently of tissue factor. Evidence for and against this hypothesis is discussed regarding its implications for treating hemophilia.

Area of Science:

  • Hematology
  • Biochemistry
  • Physiology

Background:

  • Blood coagulation is initiated by the interaction of factor VII with tissue factor upon vascular injury.
  • This complex triggers a cascade leading to fibrin clot formation.
  • The precise role of platelets in initiating coagulation remains incompletely understood.

Purpose of the Study:

  • To review the evidence supporting the hypothesis that platelets bind activated factor VIIa independently of tissue factor.
  • To explore the implications of this interaction for treating hemophilia and related syndromes.
  • To discuss alternative mechanisms for high-dose factor VIIa efficacy in hemophilic patients with inhibitors.

Main Methods:

  • Literature review of existing studies and hypotheses.

Related Experiment Videos

  • Analysis of evidence for and against platelet binding of factor VIIa.
  • Discussion of clinical implications and alternative mechanisms.

    • Main Results:

    • The hypothesis of direct platelet binding of factor VIIa is presented as a potential explanation for its therapeutic use.
    • Evidence supporting and refuting this direct interaction is critically evaluated.
    • Alternative explanations for the efficacy of high-dose factor VIIa are considered.

    Conclusions:

    • The direct role of platelets in initiating coagulation via factor VIIa binding requires further investigation.
    • Understanding this interaction is crucial for optimizing treatments for hemophilia and other bleeding disorders.
    • Alternative mechanisms may contribute to the effectiveness of high-dose factor VIIa therapy.